Literature DB >> 6368591

The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).

S M Grundy, S P Lan, J Lachin.   

Abstract

The National Cooperative Gallstone Study was a double-masked trial conducted to determine the efficacy and safety of chenodeoxycholic acid (chenodiol) for dissolution of cholesterol gallstones. Patients with radiolucent gallstones were randomly allocated to either a high dose (750 mg/d, n = 305) or low dose (375 mg/d, n = 306) of chenodiol or placebo (n = 305) administered for 2 yr. Specimens of gallbladder bile were obtained for biliary lipid analysis on 50% of all white obtained for biliary lipid analysis on 50% of all white patients at base line and after 3-mo therapy, on 45% at 12 mo, and on 36% at 24 mo. Among these specimens, 20% were inadequate for analysis. For analysis of data, available values during therapy were averaged up to time of dissolution, study exit, or study termination. In the high-dose group, percent chenodiol (molar percent of all bile acids) increased markedly and remained high during the 2 yr of follow-up. Also, molar percent cholesterol decreased significantly and remained low during the 2 yr of follow-up. In the low-dose group, percent chenodiol increased and remained significantly increased. Percent cholesterol saturation decreased at 3 mo, but at 24 mo it was not different from that in the placebo group, suggesting a physiological adaptation to the low dose by 2 yr. 79% of patients on high dose had greater than 70% chenodiol. Among these, half showed unsaturated bile (less than 100% cholesterol saturation) while the remainder were supersaturated; in the former group with unsaturated bile, 23% had complete dissolution and 51% had partial (greater than 50% reduction in stone size) or complete dissolution. In contrast, those with over 70% chenodiol and supersaturated bile had only 5% complete dissolution. Thus, development of unsaturated bile was a major factor associated with gallstone dissolution. The data also indicate that values for percent cholesterol saturation were a better predictor of gallstone dissolution than molar percent chenodiol, although a high percent chenodiol usually was required to obtain unsaturation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368591      PMCID: PMC425129          DOI: 10.1172/JCI111301

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.

Authors:  J L Thistle; A F Hofmann
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

2.  Gallstone dissolution in man using chenodeoxycholic acid.

Authors:  G D Bell; B Whitney; R H Dowling
Journal:  Lancet       Date:  1972-12-09       Impact factor: 79.321

3.  Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.

Authors:  P J Thomas; A F Hofmann
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

4.  Induced alterations in composition of bile of persons having cholelithiasis.

Authors:  J L Thistle; L J Schoenfield
Journal:  Gastroenterology       Date:  1971-10       Impact factor: 22.682

5.  The solubility of cholesterol in aqueous solutions of bile salts and lecithin.

Authors:  F G Hegardt; H Dam
Journal:  Z Ernahrungswiss       Date:  1971-04

6.  Analysis of categorical data by linear models.

Authors:  J E Grizzle; C F Starmer; G G Koch
Journal:  Biometrics       Date:  1969-09       Impact factor: 2.571

7.  Dissolution of cholesterol gallstones by chenodeoxycholic acid.

Authors:  R G Danzinger; A F Hofmann; L J Schoenfield; J L Thistle
Journal:  N Engl J Med       Date:  1972-01-06       Impact factor: 91.245

8.  Effects of obesity and caloric intake on biliary lipid metabolism in man.

Authors:  L J Bennion; S M Grundy
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

9.  Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.

Authors:  I Makino; H Hashimoto; K Shinozaki; K Yoshino; S Nakagawa
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

10.  Mechanisms of lithogenic bile formation in American Indian women with cholesterol gallstones.

Authors:  S M Grundy; A L Metzger; R D Adler
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

View more
  4 in total

Review 1.  Evidence-based clinical practice guidelines for cholelithiasis 2016.

Authors:  Susumu Tazuma; Michiaki Unno; Yoshinori Igarashi; Kazuo Inui; Kazuhisa Uchiyama; Masahiro Kai; Toshio Tsuyuguchi; Hiroyuki Maguchi; Toshiyuki Mori; Koji Yamaguchi; Shomei Ryozawa; Yuji Nimura; Naotaka Fujita; Keiichi Kubota; Junichi Shoda; Masami Tabata; Tetsuya Mine; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-12-10       Impact factor: 7.527

2.  Hepatic insulin resistance directly promotes formation of cholesterol gallstones.

Authors:  Sudha B Biddinger; Joel T Haas; Bian B Yu; Olivier Bezy; Enxuan Jing; Wenwei Zhang; Terry G Unterman; Martin C Carey; C Ronald Kahn
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440

3.  Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones.

Authors:  K von Bergmann; A Beck; C Engel; O Leiss
Journal:  Klin Wochenschr       Date:  1987-05-15

4.  Solitary versus multiple cholesterol gallbladder stones. Mechanisms of formation and growth.

Authors:  C Wolpers; A F Hofmann
Journal:  Clin Investig       Date:  1993-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.